|
|
|
|
| LEADER |
00000pam a22000004a 4500 |
| 001 |
5614271 |
| 003 |
ICU |
| 005 |
20060213150600.0 |
| 008 |
040413s2005 paua b 001 0 eng |
| 010 |
|
|
|a 2004048276
|
| 020 |
|
|
|a 0781746124
|
| 040 |
|
|
|a DNLM/DLC
|c DLC
|d DLC
|d UtOrBLW
|d OrLoB-B
|
| 042 |
|
|
|a pcc
|
| 050 |
0 |
0 |
|a RS200
|b .A57 2005
|
| 060 |
1 |
0 |
|a QV 785
|b A427a 2005
|
| 082 |
0 |
0 |
|a 615/.1
|2 22
|
| 100 |
1 |
|
|a Allen, Loyd V.
|c Jr.
|1 http://viaf.org/viaf/29855368
|
| 245 |
1 |
0 |
|a Ansel's pharmaceutical dosage forms and drug delivery systems /
|c Loyd V. Allen Jr., Nicholas G. Popovich, Howard C. Ansel.
|
| 246 |
3 |
0 |
|a Pharmaceutical dosage forms and drug delivery systems
|
| 250 |
|
|
|a 8th ed.
|
| 260 |
|
|
|a Philadelphia :
|b Lippincott Williams & Wilkins,
|c c2005.
|
| 300 |
|
|
|a xi, 738 p. :
|b ill. ;
|c 26 cm.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
| 500 |
|
|
|a Rev. ed. of: Pharmaceutical dosage forms and drug delivery systems / Howard C. Ansel, Loyd V. Allen, Jr., Nicholas G. Popovich. 7th ed. c1999.
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
0 |
|t List of physical pharmacy capsules --
|g 1.
|t Introduction to drugs and pharmacy --
|g 2.
|t New drug development and approval process --
|g 3.
|t Current good manufacturing practices and current good compounding practices --
|g 4.
|t Dosage form design : pharmaceutical and formulation considerations --
|g 5.
|t Dosage form design : biopharmaceutical and pharmacokinetic considerations --
|g 6.
|t Powders and granules --
|g 7.
|t Capsules --
|g 8.
|t Tablets --
|g 9.
|t Solid oral modified-release dosage forms and drug delivery systems --
|g 10.
|t Ointments, creams, and gels --
|g 11.
|t Transdermal drug delivery systems --
|g 12.
|t Suppositories and inserts --
|g 13.
|t Solutions --
|g 14.
|t Disperse systems --
|g 15.
|t Parenterals --
|g 16.
|t Biologics --
|g 17.
|t Special solutions and suspensions --
|g 18.
|t Radiopharmaceuticals --
|g 19.
|t Products of biotechnology --
|g 20.
|t Novel dosage forms and drug delivery technologies.
|
| 650 |
|
0 |
|a Drugs
|x Dosage forms.
|0 http://id.loc.gov/authorities/subjects/sh85039727
|
| 650 |
|
0 |
|a Drug delivery systems.
|0 http://id.loc.gov/authorities/subjects/sh88007108
|
| 650 |
1 |
2 |
|a Dosage Forms.
|
| 650 |
2 |
2 |
|a Drug Delivery Systems.
|
| 650 |
|
7 |
|a Drug delivery systems.
|2 fast
|0 http://id.worldcat.org/fast/fst00898667
|
| 650 |
|
7 |
|a Drugs
|x Dosage forms.
|2 fast
|0 http://id.worldcat.org/fast/fst00898801
|
| 700 |
1 |
|
|a Popovich, Nicholas G.
|0 http://id.loc.gov/authorities/names/n88125747
|1 http://viaf.org/viaf/92971240
|
| 700 |
1 |
|
|a Ansel, Howard C.,
|d 1933-
|0 http://id.loc.gov/authorities/names/n80009964
|1 http://viaf.org/viaf/111059703
|
| 700 |
1 |
|
|a Ansel, Howard C.,
|d 1933-
|t Pharmaceutical dosage forms and drug delivery systems.
|
| 901 |
|
|
|a ToCBNA
|
| 903 |
|
|
|a HeVa
|
| 035 |
|
|
|a (OCoLC)55008304
|
| 929 |
|
|
|a cat
|
| 999 |
f |
f |
|i 0bc80959-4cf8-5a49-8e64-ec44ac3b9f83
|s d20e12b5-6c04-5051-aa25-424d34a8aeb5
|
| 928 |
|
|
|t Library of Congress classification
|a RS200 .A57 2005
|l JCL
|c JCL-Sci
|i 4840026
|
| 927 |
|
|
|t Library of Congress classification
|a RS200 .A57 2005
|l JCL
|c JCL-Sci
|e BILL
|e CRERAR
|b 70161054
|i 7835573
|
